Newron Pharmaceuticals Market Cap

Newron Pharmaceuticals has a market cap or net worth of €156.24 million as of June 6, 2025. Its market cap has decreased by -21.94% in one year.

Market Cap

156.24M

Enterprise Value

197.01M

Revenue

51.39M

Ranking

n/a

PE Ratio

9.86

Stock Price

€7.86

Market Cap Chart

Since December 12, 2006, Newron Pharmaceuticals's market cap has decreased from 194.15M to 156.24M, a decrease of -19.53%. That is a compound annual growth rate of -1.17%.

Market Cap History

Date	Market Cap	% Change
Jun 4, 2025	156.24M	-15.57%
Dec 30, 2024	185.06M	94.99%
Dec 29, 2023	94.91M	239.07%
Dec 30, 2022	27.99M	0.21%
Dec 30, 2021	27.93M	-20.96%
Dec 30, 2020	35.34M	-66.13%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 30, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
SAP SE	310.20B
Siemens Aktiengesellschaft	165.29B
Deutsche Telekom AG	162.35B
Allianz SE	133.84B
Rheinmetall AG	85.79B
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München	74.51B
Siemens Energy AG	67.56B
Deutsche Börse AG	52.10B

Market Cap Rankings